SCHEMBL10077425

SCHEMBL10077425

Cc1ncc(C)c2c(C(=O)C(=O)N3CCN(c4c(-c5ccccc5)c(=O)c4=O)CC3)c[nH]c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.43
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2B6 P20813 1/20 0.40
KCNH2 Q12809 1/20 0.40
ALOX15 P16050 2/20 0.37
GAA P10253 1/20 0.37
ALOX12 P18054 1/20 0.37
TP53 P04637 2/20 0.36
POLB P06746 2/20 0.36
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077546 0.91 CYP2C9 (0.42) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL13898870 0.90 CYP2C9 (0.57) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL10078292 0.86 CYP2C9 (0.38) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL10078092 0.83 CYP2C9 (0.35) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL10077420 0.81 CYP2C9 (0.49) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL13898964 0.81 CYP2C9 (0.69) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL2628893 0.81 CYP2C9 (0.63) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL3938306 0.80 CYP2C9 (0.56) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL13898961 0.80 CYP2C9 (0.56) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL3934564 0.77 CYP2C9 (0.58) CYP2C9CYP3A4CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013170-B1 4-SQUARYLPIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS BRISTOL MYERS SQUIBB CO (US) 2012-06-27 EP disclosed